| |
| |
|
| Insider
Information: |
Car Bruce |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
19,135 |
|
|
Indirect Shares
|
30,000 |
|
|
| Direct
Value |
$926,896 |
|
|
|
Indirect Value
|
$1,535,400 |
|
|
| Total
Shares |
49,135 |
|
|
| Total
Value |
$2,462,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Scientific Officer |
2022-02-22 |
16,752 |
2020-04-13 |
0 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2024-06-17 |
2,383 |
2024-06-17 |
30,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BHVN |
Biohaven Ltd. |
Chief Scientific Officer |
• – – |
2024-06-17 |
4 |
B |
$33.58 |
$1,007,490 |
I/I |
30,000 |
30,000 |
0.01 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-22 |
4 |
D |
$29.08 |
$59,352 |
D/D |
(2,041) |
16,752 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,874 |
18,793 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-10 |
4 |
D |
$31.43 |
$33,719 |
D/D |
(1,073) |
11,919 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,667 |
12,992 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-01-06 |
4 |
D |
$32.58 |
$39,259 |
D/D |
(1,205) |
9,325 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,437 |
10,530 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-06 |
4 |
D |
$44.09 |
$52,506 |
D/D |
(1,191) |
7,093 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,437 |
8,284 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-04-14 |
4 |
D |
$40.64 |
$82,377 |
D/D |
(2,027) |
4,847 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,874 |
6,874 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
